argenx to Report Half Year 2021 Financial Results and Second Quarter Business Update on July 29, 2021
22 Juillet 2021 - 7:00AM
July 22, 2021Breda, the
Netherlands – argenx (Euronext & Nasdaq: ARGX), a
global immunology company committed to improving the lives of
people suffering from severe autoimmune diseases and cancer, today
announced that it will host a conference call and audio webcast on
Thursday, July 29, 2021 at 2:30 p.m. CET (8:30 a.m. ET) to discuss
its half year 2021 financial results and provide a second quarter
business update.
A webcast of the live call may be accessed on
the Investors section of the argenx website at
argenx.com/investors. A replay of the webcast will be available on
the argenx website for approximately one year following the
call.
Dial-in numbers:Please dial in
15 minutes prior to the live call.
Belgium
0800
389 13France
0805
102
319Netherlands 0800
949 4506United Kingdom
0800 279 9489United
States 1 844 808 7140
International
1 412 902 0128
About argenx
argenx is a global immunology company committed to improving the
lives of people suffering from severe autoimmune diseases and
cancer. Partnering with leading academic researchers through its
Immunology Innovation Program (IIP), argenx aims to translate
immunology breakthroughs into a world-class portfolio of novel
antibody-based medicines. argenx is evaluating efgartigimod in
multiple serious autoimmune diseases. argenx is also advancing
several earlier stage experimental medicines within its therapeutic
franchises. argenx has offices in Belgium, the United States,
Japan, and Switzerland. For more information, visit www.argenx.com
and follow us on LinkedIn at
https://www.linkedin.com/company/argenx/ and Twitter at
https://twitter.com/argenxglobal.
For further information, please contact:
Media:Kelsey Kirkkkirk@argenx.com
Joke Comijn jcomijn@argenx.com
Investors:
Beth DelGiaccobdelgiacco@argenx.com
Michelle Greenblattmgreenblatt@argenx.com
Argen X (EU:ARGX)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Argen X (EU:ARGX)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024
